Open for inclusion

An exploratory Phase I Study with Sorafenib in Addition to Vinflunine in Progressive Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract

Cancer type: Urothelial

Phase: I

Principal Investigator: Ullén Anders

Country: SE

Keywords: Sweden, VINSOR (NUCOG III), Urothelial cancer, Vinflunine, Sorafenib, second line

Status: Open for inclusion

Link to